Breast Cancer

Showing NaN - NaN of 217

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Breast Cancer Trial in Worldwide (DS-8201a)

Active, not recruiting
  • Breast Cancer
  • Anchorage, Alaska
  • +98 more
Oct 17, 2022

Local Recurrence Following Breast Conserving Surgery and

Active, not recruiting
  • Breast Cancer
    • Calgary, Alberta, Canada
    • +26 more
    Sep 19, 2022

    Breast Cancer, Cholangiocarcinoma, Colorectal Cancer Trial in Worldwide (Entrectinib)

    Recruiting
    • Breast Cancer
    • +15 more
    • Goodyear, Arizona
    • +146 more
    Aug 24, 2022

    Ovarian Cancer, Breast Cancer Trial in Worldwide (Olaparib)

    Enrolling by invitation
    • Ovarian Cancer
    • Breast Cancer
    • Boca Raton, Florida
    • +98 more
    Aug 22, 2022

    Breast Cancer Trial in United Kingdom (AZD4547 / anastrozole or letrozole)

    Completed
    • Breast Cancer
    • AZD4547 / anastrozole or letrozole
    • Burton-on-Trent, Staffs, United Kingdom
    • +6 more
    Apr 20, 2022

    Breast Cancer Trial in Worldwide (LY3484356)

    Recruiting
    • Breast Cancer
    • Atlanta, Georgia
    • +19 more
    Aug 17, 2022

    Breast Cancer Trial in Worldwide (Trastuzumab deruxtecan, Capecitabine, Lapatinib)

    Active, not recruiting
    • Breast Cancer
    • Trastuzumab deruxtecan
    • +3 more
    • Chandler, Arizona
    • +226 more
    Aug 11, 2022

    Melanoma, Breast Cancer, Uterine Cancer Trial in London (MRx0518 Capsules, MRx0518/ Capsules)

    Active, not recruiting
    • Melanoma
    • +9 more
    • MRx0518 Capsules
    • MRx0518/placebo Capsules
    • London, United Kingdom
      Imperial College Healthcare NHS Trust
    Aug 10, 2022

    Histolog Comparison to Standard Histology

    Active, not recruiting
    • Margins of Excision
    • Breast Cancer
    • Histolog Scanner
    • London, United Kingdom
      Imperial College NHS Trust
    Aug 9, 2022

    Breast Cancer Trial in Australia, Canada, New Zealand (Ipatasertib, Fulvestrant, Placebo)

    Recruiting
    • Breast Cancer
    • Bowral, New South Wales, Australia
    • +37 more
    Aug 8, 2022

    Carcinoma, Ductal, Breast, Breast Cancer, Breast Tumor Trial in Worldwide (G1T38, Fulvestrant)

    Active, not recruiting
    • Carcinoma, Ductal, Breast
    • +2 more
    • Sofia, Bulgaria
    • +7 more
    Aug 1, 2022

    Breast Cancer Trial in Worldwide (Abemaciclib, Anastrozole, Letrozole)

    Active, not recruiting
    • Breast Cancer
    • Chandler, Arizona
    • +166 more
    Jul 21, 2022

    Breast Cancer Trial in Worldwide (biological, drug, other, procedure)

    Active, not recruiting
    • Breast Cancer
    • nivolumab
    • +6 more
    • Mobile, Alabama
    • +255 more
    Jul 21, 2022

    Breast Cancer Trial in Worldwide (Elacestrant, Standard of Care)

    Active, not recruiting
    • Breast Cancer
    • Tucson, Arizona
    • +167 more
    Jul 19, 2022

    Glioblastoma, Melanoma Stage IV, Melanoma Recurrent Trial in United Kingdom, United States (ST101)

    Recruiting
    • Glioblastoma
    • +11 more
    • San Francisco, California
    • +11 more
    Jul 13, 2022

    Ovarian Cancer, Breast Cancer, Pancreatic Cancer Trial in Worldwide (AZD5305, Paclitaxel, Carboplatin)

    Recruiting
    • Ovarian Cancer
    • +12 more
    • San Francisco, California
    • +44 more
    Jul 12, 2022

    Breast Cancer Trial in Worldwide (Ribociclib, Letrozole, Goserelin)

    Active, not recruiting
    • Breast Cancer
    • Anchorage, Alaska
    • +495 more
    Jun 15, 2022

    Breast Cancer, Hypercalcemia of Malignancy, Metastatic Cancer Trial in United Kingdom (zoledronic acid, quality-of-life

    Terminated
    • Breast Cancer
    • +4 more
    • zoledronic acid
    • quality-of-life assessment
    • Bournemouth, England, United Kingdom
    • +29 more
    May 23, 2022

    Breast Cancer Trial in London (Radiotherapy before surgery)

    Completed
    • Breast Cancer
    • Radiotherapy before surgery
    • London, United Kingdom
      The Royal Marsden NHS Foundation Trust
    Apr 26, 2022

    Breast Cancer Trial in Worldwide (Trastuzumab deruxtecan (T-DXd), Ado-trastuzumab emtansine (T-DM1))

    Active, not recruiting
    • Breast Cancer
    • Trastuzumab deruxtecan (T-DXd)
    • Ado-trastuzumab emtansine (T-DM1)
    • Los Angeles, California
    • +163 more
    Apr 1, 2022

    Breast Cancer, Surgical Site Infection, Wound Dehiscence Trial in London (Negative Pressure Wound Therapy)

    Not yet recruiting
    • Breast Cancer
    • +2 more
    • Negative Pressure Wound Therapy
    • London, Ontario, Canada
      London Health Sciences Centre
    Apr 20, 2022

    Breast Cancer Trial in Worldwide (Ipatasertib, Paclitaxel, Atezolizumab)

    Completed
    • Breast Cancer
    • Long Beach, California
    • +17 more
    Apr 22, 2022

    Ontario-wide Cancer TArgeted Nucleic Acid Evaluation

    Recruiting
    • Breast Cancer
    • +10 more
      • Hamilton, Ontario, Canada
      • +6 more
      Apr 21, 2022